The independent source for health policy research, polling, and news.
2,461 - 2,480 of 3,883 Results
In states that take up the bill’s option to change the essential health benefits, the out-of-pocket spending limits and annual and lifetime caps on coverage in large group plans could fray.
A new law gives Medicaid regulators power to threaten drugmakers with cost-effectiveness scrutiny unless they grant additional rebates.
Legislation would require minimum staffing levels, longer intervals between patients and more frequent state inspections.
The company, which is the nation’s largest Medicare Advantage operator, denies wrongdoing and argues that the Justice Department “fundamentally misunderstands” how Medicare Advantage works.
With flawed systems for tracking the side effects of prescription drugs, a link between proton pump inhibitors and kidney disease suggested by research cannot be proven. Patients who swear by the drugs hope it won’t be.
The Buffalo News reports the Buffalo, N.Y.-area Republican has drawn inquiries from the Office of Congressional Ethics related to his investment in Australian biotech company Innate Immunotherapeutics.
Even the most exalted among us realize health care policy is complicated. Here's a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
A look at how and why strategic, star-studded advertising brought a drug for a little-known neurological condition into your home.
Starting in fall 2015, Houston-based Memorial Hermann Health System began to examine the food struggles among patients at four medical sites and found that 11 percent to 30 percent said they had run out of food in the prior month or thought that they would.
The two Republican lawmakers sent a letter to HHS Secretary Tom Price warning him that whistleblowers in HHS could be intimidated into silence by a department memo instructing employees to get clearance before talking with members of Congress and their staffs.
More than 70 drugs approved from 2001 through 2010 ran into safety concerns later that resulted in withdrawals from the market, “black box” warnings or other actions.
A bill pending in California’s Legislature, sponsored by an influential health care union, would require hospitals and clinics to pay minimum wage to student trainees.
House Republicans can say they kept their campaign promise to replace Obamacare, but they’re counting on the Senate to backstop them.
CEO Paul Markovich said he opposes the Republican plan because it would allow insurers to once again discriminate against people with preexisting conditions. "We are better than that," he said.
Hospitals and oncology practices are setting up urgent care services aimed specifically at cancer patients to help keep them out of the hospital.
Ombudsman's offices represent long-term care residents on issues such as admissions and discharges, food, physical environment and abuse.
Interest in medical schools is high in Puerto Rico, but many students look to the U.S. mainland for residencies because of higher pay and the commonwealth's declining economy. The migration of young talent is both a symptom and an exacerbation of the island’s medical woes.
A program designed to address the shortage of doctors in rural and poor urban areas could be in peril unless Congress acts.
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
A critical shortage of home health care workers across the U.S. is denying care for senior citizens and people with disabilities.
© 2026 KFF